Tag: ICH

Viz.ai gains US FDA 510(k) clearance for intracerebral haemorrhage imaging algorithm

Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended...

Female hormone intake and its influence on cerebral cavernous malformations

As per an observational study published in the journal Neurology last year, female hormone therapy use may be associated with a higher risk of...

Global experts call for tighter standards to speed up emergency haemorrhagic...

An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for...

Apotransferrin shows promise in animal models of intracranial haemorrhage

Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH)...

Latest TRIAGE-STROKE and RACECAT data put the brakes on alternative stroke...

Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or...

AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...

Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...

“Definitive trial” needed to confirm desmopressin’s potential in ICH patients receiving...

The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the...

New ENRICH-PLUS study set to build on recent positivity in haemorrhagic...

Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000...

Latest trial results prompt call to “elevate” intracranial haemorrhage management

Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...

ENRICH trial data on minimally invasive ICH surgery to be presented...

NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...

Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...

Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...

Viz.ai collaborates with Johns Hopkins to expedite patient enrolment in brain...

Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for...

Rapid ICH receives new US FDA clearance with “highest sensitivity and...

RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...

NICO raises US$12.5 million in oversubscribed investment round

NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...

IRRAS announces educational webinar series alongside Jacobs Institute and University of...

IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...

NICO announces completed enrolment in trial evaluating new ICH intervention approach

NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...

RapidAI receives US FDA clearance for Rapid Hyperdensity

RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...

Stroke in young people may be associated with increased likelihood of...

The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...
attention evt basilar

ATTENTION results indicate “we have finally conquered the basilar artery” with...

This year’s European Stroke Organisation Conference (ESOC 2022; 4–6 May, Lyon, France) saw results from ATTENTION—a multicentre randomised controlled trial (RCT) evaluating the benefit...